Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (abcg2, abcb1) and gefitinib toxicity

Mariko Tamura, Masashi Kondo, Mihoko Horio, Maki Ando, Hiroshi Saito, Masashi Yamamoto, Yoshitsugu Horio, Yoshinori Hasegawa

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The purpose of this study is to investigate associations between allelic variations of ABCG2 and ABCB1 with skin toxicity, diarrhea, liver injury and interstitial lung disease (ILD) in gefitinib-treated patients. A prospective clinical study of 83 Japanese patients with non-small-cell lung cancer was performed. Polymorphic loci in ABCG2 and ABCB1 were genotyped, and their effects on gefitinib toxicities were evaluated. ABCG2 34G>A was statistically associated with occurrence of skin rash; 13 (42%) of the 32 patients with at least one variant ABCG2 34G>A allele (G/A and A/A) developed grade 2 or worse skin rash, whereas only 10 (19%) of 51 patients homozygous for the reference allele (G/G) for the wild-type sequence for both alleles did so (P = 0.046). There was no significant association between severe toxicities and polymorphisms of ABCG2 421C>A nor ABCB1 3435C>T. The results suggested that ABCG2 34G>A would be useful for predicting grade 2 or worse skin rash.

Original languageEnglish
Pages (from-to)133-140
Number of pages8
JournalNagoya journal of medical science
Volume74
Issue number1-2
Publication statusPublished - 01-12-2012

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (abcg2, abcb1) and gefitinib toxicity'. Together they form a unique fingerprint.

  • Cite this

    Tamura, M., Kondo, M., Horio, M., Ando, M., Saito, H., Yamamoto, M., Horio, Y., & Hasegawa, Y. (2012). Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (abcg2, abcb1) and gefitinib toxicity. Nagoya journal of medical science, 74(1-2), 133-140.